Omega Healthcare Investors: Returning To Growth In 2019, But Should You Buy?

Summary

  • Omega Healthcare Investors reported Q4-2018 results yesterday.
  • The healthcare REIT missed FFO estimates.
  • Dividend coverage was good in the last quarter, and the REIT guided for year-over-year A/FFO growth.
  • That being said, though, shares continue to be overvalued, in my opinion.
  • An investment in OHI yields 6.7 percent.

Omega Healthcare Investors (NYSE:OHI) does not make a compelling value proposition at today's price point based on valuation and risk/reward. Though Omega Healthcare Investors once again covered its dividend payout with adjusted funds from operations in the last quarter and guided for A/FFO growth this year on the back of acquisitions, the healthcare REIT is currently slightly overvalued based on AFFO. An investment in Omega Healthcare Investors at today's price point yields 6.7 percent.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect
  • Jean Halle

    Independent Consultant

    Connect
  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect
  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect
  • David Crowley

    Owner at Develop DC

    Connect
  • Carolyn Stinson

    Stinson Marketing Group

    Connect